Latvia vs Switzerland: Cases started on MDR-TB treatment
Latvia
11
in 2024
Switzerland
12
in 2024
Latvia rank
119th
Switzerland rank
116th
Cases started on MDR-TB treatment over time
- Latvia
- Switzerland
How they compare
Switzerland currently reports 12 against 11 in Latvia, a difference of 1.
That makes Switzerland's figure about 1.1 times Latvia's.
The two have swapped places 1 time across 11 shared years of data; in 2010 it was Latvia ahead.
Latvia ranks 119th and Switzerland ranks 116th of 193 countries.
Latvia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Latvia | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 115 | 9.5 | 105.5 | Latvia |
| 2020s | 13.33 | 6.67 | 6.67 | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cases started on mdr-tb treatment, Latvia or Switzerland?
- Switzerland, at 12 against 11 in Latvia as of 2024.
- What is the difference in cases started on mdr-tb treatment between Latvia and Switzerland?
- 1, with Switzerland ahead.
- How many years of comparable data are there for Latvia and Switzerland?
- 11 years are reported by both, from 2010 to 2024.
- How do Latvia and Switzerland rank globally for cases started on mdr-tb treatment?
- Latvia ranks 119th and Switzerland ranks 116th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.